Ranbaxy for more drugs in US mkt
Ranbaxy Laboratories could grow its kitty of drugs in the lucrative US market by over 50 per cent this year as it awaits the US Food and Drug Administration's (FDA) decision on 33 abbreviated new
Ranbaxy Laboratories could grow its kitty of drugs in the lucrative US market by over 50 per cent this year as it awaits the US Food and Drug Administration's (FDA) decision on 33 abbreviated new